Press Releases Archive
2003
Collaborative Agreement Between Amgen Inc. and Tularik Inc.
The California based biotech companies Amgen and Tularik have embarked on a close collaborative effort in the field of oncology (cancer treatment). Amgen has contributed 20 percent of its own capital to this partnership with Tularik and in a separate move has bought six million shares of Tularik’s common stocks. Tularik will in return receive 125 mill. US$ (110 mill. Euro) from Amgen.
read onSuccessful Round Financing for Profos AG
In spite of the current crisis in the venture capital arena, the Regensburg biotech company Profos AG has been able to convince the well-known international Danisco Venture Investment Corporation to collaborate. Through this the company will be substantially sustained and the basis for stronger growth and accelerated development will be secured.
read onRegensburg Expands its Business Contacts in the USA
Regensburg’s Mayor Hans Schaidinger has led another delegation to partner cities and partner companies in the USA. The participation of the city of Regensburg in the world’s largest biotech trade show, Bio2003 in Washington, D.C., successfully initiated further meetings in San Francisco, Ca., San Antonio, Tx., and Germantown, Md.
read onRegensburg on Its Way to Becoming the New Center of Sensor Technology
The city of Regensburg, ten companies and the University of Regensburg signed a strategic partnership agreement intended to provide a foundation for the continued development of Regensburg into the leading sensor production center of Germany.
read onBionorica AG on the Road to Success With a New Concept
Bionorica, AG, has become one of the top three most successful pharmaceutical producers in Germany due to its novel Phytoneering-concept. The company recorded a profit of 57 million Euro in 2002. Recently, 7 million Euro (13% of the profits) were invested in research.
read onPage 2 of 3
ARCHIVE